Molecules/MONALIZUMAB

MONALIZUMAB

Molecular Identity

AntibodyPhase 3

Mechanism of action: NKG2-A/NKG2-B type II integral membrane protein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

IPH-2201IPH2201IPH-2201 (ANTI-NKG2A)MONALIZUMABNN-8765NN8765NN8765-3658

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to MONALIZUMAB

Loading drug network...